Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 325

Similar articles for PubMed (Select 18490492)

1.

Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis.

Hömig-Hölzel C, Hojer C, Rastelli J, Casola S, Strobl LJ, Müller W, Quintanilla-Martinez L, Gewies A, Ruland J, Rajewsky K, Zimber-Strobl U.

J Exp Med. 2008 Jun 9;205(6):1317-29. doi: 10.1084/jem.20080238. Epub 2008 May 19.

2.

LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1.

Rastelli J, Hömig-Hölzel C, Seagal J, Müller W, Hermann AC, Rajewsky K, Zimber-Strobl U.

Blood. 2008 Feb 1;111(3):1448-55. Epub 2007 Nov 15.

4.
5.

MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.

Ho L, Davis RE, Conne B, Chappuis R, Berczy M, Mhawech P, Staudt LM, Schwaller J.

Blood. 2005 Apr 1;105(7):2891-9. Epub 2004 Dec 14.

6.

Cooperation of multiple signaling pathways in CD40-regulated gene expression in B lymphocytes.

Dadgostar H, Zarnegar B, Hoffmann A, Qin XF, Truong U, Rao G, Baltimore D, Cheng G.

Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1497-502.

8.

Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.

Qiao G, Lei M, Li Z, Sun Y, Minto A, Fu YX, Ying H, Quigg RJ, Zhang J.

J Immunol. 2007 Oct 1;179(7):4473-9.

9.

Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.

Qian Y, Qin J, Cui G, Naramura M, Snow EC, Ware CF, Fairchild RL, Omori SA, Rickert RC, Scott M, Kotzin BL, Li X.

Immunity. 2004 Oct;21(4):575-87.

PMID:
15485634
10.

CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis.

Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE.

J Biol Chem. 2007 Jun 15;282(24):17475-85. Epub 2007 Apr 19.

11.

A novel mechanism for TNFR-associated factor 6-dependent CD40 signaling.

Rowland SL, Tremblay MM, Ellison JM, Stunz LL, Bishop GA, Hostager BS.

J Immunol. 2007 Oct 1;179(7):4645-53.

12.

Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation.

Sasaki Y, Derudder E, Hobeika E, Pelanda R, Reth M, Rajewsky K, Schmidt-Supprian M.

Immunity. 2006 Jun;24(6):729-39.

13.

TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival.

Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y.

Immunity. 1997 Nov;7(5):703-13.

15.

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.

Uchida J, Yasui T, Takaoka-Shichijo Y, Muraoka M, Kulwichit W, Raab-Traub N, Kikutani H.

Science. 1999 Oct 8;286(5438):300-3.

16.

CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.

Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G, Lamy T, Fest T, Tarte K, Guillaudeux T.

J Immunol. 2008 Jul 15;181(2):1001-11.

17.

Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.

Xie P, Hostager BS, Munroe ME, Moore CR, Bishop GA.

J Immunol. 2006 May 1;176(9):5388-400.

18.

TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells.

Grech AP, Amesbury M, Chan T, Gardam S, Basten A, Brink R.

Immunity. 2004 Nov;21(5):629-42.

PMID:
15539150
19.

Human T cell leukemia virus type I Tax activates CD40 gene expression via the NF-kappa B pathway.

Harhaj EW, Harhaj NS, Grant C, Mostoller K, Alefantis T, Sun SC, Wigdahl B.

Virology. 2005 Mar 1;333(1):145-58.

20.

Signaling and protein associations of a cell permeable CD40 complex in B cells.

Zoog SJ, Papov VV, Pullen SS, Jakes S, Kehry MR.

Mol Immunol. 2004 Jan;40(10):681-94.

PMID:
14644094
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk